What does this research mean for the field?

e1a2 BCR::ABL1 chronic myeloid leukemia frequently arises within complex, premutated clonal backgrounds (often involving ASXL1 and TET2), which provides a biological basis for its atypical clinical presentation and heterogeneous treatment response. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to explore the unique clinical and genomic characteristics of e1a2 BCR::ABL1 chronic myeloid leukemia (CML).

August 1, 2026HemaSphereOpen Access

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi‐LMC study

View Full Paper

Ask AI

Bookmark

Authors

BPBenjamin PodvinInserm ONOlivier NibourelCentre National de la Recherche Scientifique SHSandrine HayetteHospices Civils de Lyon

Discussion

Member takes

Implication

Randomized trial investigates clonal and genomic features in e1a2 BCR::ABL1 chronic myeloid leukemia, suggesting complex backgrounds contribute to disease presentation.

Key Points

This research aims to explore the unique clinical and genomic characteristics of e1a2 BCR::ABL1 chronic myeloid leukemia (CML).
Analyzed a cohort of 60 patients with CML, comparing e1a2 BCR::ABL1 cases with e13a2/e14a2 cases.
Investigated somatic mutations and clonal architectures through longitudinal tracking and single-cell genotyping.
Evaluated hematologic features and treatment responses linked to the e1a2 transcript.
Identified lower leukocyte and platelet counts and higher monocytosis in e1a2 patients (12.3% vs. 2.0%, P < 0.001).
Found additional somatic mutations in 88% of e1a2 cases, dominated by ASXL1 and TET2, versus 17% in e13a2/e14a2 cases.
Tracked distinct clonal architectures with 71% of mutations disappearing after treatment, while 29% showed stable VAFs, suggesting complex pre-existing conditions.

Cite This Study

Podvin et al. (2026) studied this question.

synapsesocial.com/papers/6a72ad3f84cc45bb7be0276f https://doi.org/10.1002/hem3.70454

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial investigates clonal and genomic features in e1a2 BCR::ABL1 chronic myeloid leukemia, suggesting complex backgrounds contribute to disease presentation.

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi‐LMC study

Discussion

Member takes

Implication

Key Points

Cite This Study

Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi‐LMC study

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider